Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/IN/Evansville
Updated September 2026 from ClinicalTrials.gov

Paid Clinical Trials in Evansville, IN

Studies commonly pay $75 to $4,500 per completed study

70 clinical trials are currently recruiting participants within 30 miles of Evansville. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

70studies recruiting
2+research centers nearby
6condition categories
Live from the NIH registry

Studies recruiting near Evansville right now

Top 25 of 70 recruiting studies, sorted by proximity — each links to its official registry page

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

Diffuse Large B-Cell Lymphoma Phase 3 Interventional 1,046 participants sought
Owensboro Medical Health System ( Site 0195) — Owensboro, Kentucky (27.3 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06717347)

Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma Phase 3 Interventional 269 participants sought
Owensboro Health Mitchell Memorial Cancer Center — Owensboro, Kentucky (27.3 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06500455)

A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System

Atrial Fibrillation N/A Interventional 276 participants sought
Deaconess Gateway Hospital — Newburgh, Indiana (7.6 mi) · Sponsor: Biosense Webster, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07227532)

Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy

Diabetic Peripheral Neuropathic Pain Phase 3 Interventional 1,100 participants sought
Synexus Clinical Research - Evansville — Evansville, Indiana (1.5 mi) · Sponsor: Vertex Pharmaceuticals Incorporated
See eligibility & contact on ClinicalTrials.gov (NCT06628908)

A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)

Asthma Phase 3 Interventional 110 participants sought
GSK Investigational Site — Owensboro, Kentucky (27.3 mi) · Sponsor: GlaxoSmithKline
See eligibility & contact on ClinicalTrials.gov (NCT07645248)

A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis

Moderate-to-Severe Atopic Dermatitis Phase 3 Interventional 510 participants sought
Nektar Investigative Site — Owensboro, Kentucky (27.3 mi) · Sponsor: Nektar Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT07690371)

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Breast Neoplasms, Neoplasm Metastasis Phase 3 Interventional 800 participants sought
Deaconess GI Specialty Center — Newburgh, Indiana (7.6 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT07174336)

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Diabetes Mellitus, Type 2, Hypertension Phase 3 Interventional 11,800 participants sought
Research Integrity, LLC — Owensboro, Kentucky (27.3 mi) · Sponsor: Boehringer Ingelheim
See eligibility & contact on ClinicalTrials.gov (NCT07064473)

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

Small Cell Lung Cancer Phase 3 Interventional 531 participants sought
Deaconess Midtown Hospital /ID# 282134 — Evansville, Indiana (1.5 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT07365241)

BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease

HR+/HER2- Breast Cancer Phase 3 Interventional 1,056 participants sought
Owensboro Health Mitchell Memorial Cancer Center — Owensboro, Kentucky (27.3 mi) · Sponsor: BeOne Medicines
See eligibility & contact on ClinicalTrials.gov (NCT07492641)

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Obesity, Overweight Phase 3 Interventional 3,003 participants sought
AURORA-1 Clinical Site — Evansville, Indiana (1.5 mi) · Sponsor: Ascletis Pharma (China) Co., Limited
See eligibility & contact on ClinicalTrials.gov (NCT07743463)

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

Metabolic Dysfunction-Associated SteatoHepatitis (MASH) Phase 2 Interventional 120 participants sought
Deaconess Clinic - GI Specialty Center — Newburgh, Indiana (7.6 mi) · Sponsor: Regeneron Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT05519475)

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

Heart Failure, Heart Failure With Reduced Ejection Fraction Phase 3 Interventional 1,800 participants sought
Deaconess Heart Group — Newburgh, Indiana (7.6 mi) · Sponsor: Cytokinetics
See eligibility & contact on ClinicalTrials.gov (NCT06736574)

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

Osteoarthritis, Overweight or Obesity Phase 3 Interventional 900 participants sought
Qualmedica Research, LLC — Evansville, Indiana (1.5 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT07353931)

Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

Atrial Fibrillation (AF) Phase 3 Interventional 2,500 participants sought
Anthos Investigative Site 9915 — Evansville, Indiana (1.5 mi) · Sponsor: Anthos Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT05712200)

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Phase 2 Interventional 40 participants sought
Ohio State University Telemedicine — Evansville, Indiana (1.5 mi) · Sponsor: Sameek Roychowdhury
See eligibility & contact on ClinicalTrials.gov (NCT06906562)

A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis

Arthritis, Psoriatic Phase 2 Interventional 240 participants sought
Qualmedica Research — Evansville, Indiana (1.5 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT07321873)

A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines

Chronic Spontaneous Urticaria (CSU) Phase 3 Interventional 400 participants sought
Deaconess Clin Allerg Res Inst — Evansville, Indiana (1.5 mi) · Sponsor: Novartis Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT06868212)

A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus Phase 3 Interventional 1,200 participants sought
Research Site — Evansville, Indiana (1.5 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT07662213)

A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF

Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF) Phase 3 Interventional 6,950 participants sought
Research Site — Owensboro, Kentucky (27.3 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT07761117)

A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

Carcinoma, Non-Small-Cell Lung Phase 3 Interventional 630 participants sought
Owensboro Medical Health System — Owensboro, Kentucky (27.3 mi) · Sponsor: Mirati Therapeutics Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06875310)
Actively enrolling

Studies you may be able to join near Evansville

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Evansville

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

MediSphere Medical Research Center

★ 5.0
4411 Washington Ave Ste 147, Evansville, IN 47714
(812) 471-4110
"Good people who care about there people. For medical research ."
— Troy Christian, 5★

Qualmedica Research

5015 Plaza E Blvd, Evansville, IN 47715
(812) 205-2475

Clinical trials in Evansville: what's recruiting

The Evansville area currently has 70 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Evansville, the most active research areas are:

  • Cancer & Oncology6 studies
  • Diabetes & Metabolism6 studies
  • Immune & Skin4 studies
  • Heart & Vascular3 studies
  • Liver & Kidney2 studies

Every listing shows the study phase, the recruiting site and its distance from Evansville, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Evansville

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Evansville participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Evansville pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Are clinical trials in Evansville safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Evansville, IN?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
How often do new paid studies open in Evansville?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Evansville.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Evansville typically complete one or two studies per year.

Paid clinical trials near Evansville

Other metros within reach

Clarksville, TN8 Louisville, KY557 Nashville, TN1,330 Champaign, IL170 Indianapolis, IN928 Murfreesboro, TN79 Lafayette, IN36 Springfield, IL182

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Evansville Bladder Issues Due To Spinal Cord Injury in Evansville All conditions

More of IN

Indianapolis928 Fort Wayne118 Elkhart106 South Bend106 Lafayette36

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts